Community/Retail

Embedding a pharmacist in the dermatology clinic improved clinical and financial outcomes.

QPL use in the pharmacy setting may enhance patient engagement while allowing pharmacists to showcase their medication-related expertise.

Coinfection with RSV and hRV is linked to a higher prevalence of lower respiratory tract infections, according to new data.

Many patients may struggle to understand the complex immunization schedules compiled by the CDC.

Research suggests H5N1 may be spreading undetected among humans, particularly in veterinarians with frequent animal exposure.

All stakeholders should work together to determine and address drug shortages.

Phil Vigeant shares insights on the health benefits of protein supplements and guidance for consumers to identify safe and effective protein powder products.

New data from the longest known trial of pediatrics and adolescents in the postacute phase of COVID-19 show they are at a heightened risk of gastrointestinal tract symptoms.

Donna Ryan explains why long-term treatment with GLP-1 medication is typically necessary to maintain weight loss benefits.

The approval makes the vaccine the first of its kind for this indication in the United States.

The authors are optimistic that these findings may help develop defenses to prevent food allergies in at-risk infants.

Future research can explore the underlying cause of recurrent pericarditis with systemic Sjögren syndrome and the combination of rilonacept with immunosuppressive therapies.

The authors suggest future research should consider inflammation and the gut as potential therapeutic targets improve depression in patients with chronic kidney disease (CKD).

Pharmacists should emphasize the importance of medication adherence and lifestyle changes.

Invasive meningococcal disease is a severe bacterial infection caused by the bacterium Neisseria meningitidis, often leading to meningitis or sepsis.

RSV poses a significant threat to high-risk adults, but effective vaccines offer strong protection, highlighting the need for increased vaccination rates and education.

Insulin-aspart-szjj (Merilog) is the first rapid-acting insulin biosimilar product approved by the FDA.

PP-01 could become a first-in-class treatment for patients with cannabis use disorder.

Therapies like the newly approved suzetrigine, a nonopioid NaV1.8 pain signal inhibitor, could revolutionize pain management and mitigate the risks associated with opioid use.

Treatment with 2.4 mg of semaglutide did not increase the risk of developing suicidal ideation or behavior compared with placebo.

With a wealth of available nonprescription options, patients should know about various products and their uses.

Pharmacists can help patients and their caregivers manage seizures, assess seizure control, and recommend appropriate treatments such as phenobarbital or rescue medications.

Pharmacists can help educate patients, identify adverse events, and help patients communicate with other health care professionals or drug companies.

After gradually consuming increased doses of peanut butter, children who could initially tolerate about half a peanut could consume 3 tablespoons without an allergic reaction.

Through frequent interactions, pharmacists can discuss patients' treatment satisfaction, adherence issues, or potential adverse events.

Diabetes management through insulin could play a significant role in preventing antibiotic resistance.

The agency will now review the novel PCSK9 inhibitor for possible approval in patients with or at high risk of atherosclerotic cardiovascular disease.